Radiolabeled peptides for the diagnosis and treatment of...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 7/08 (2006.01) A61K 51/08 (2006.01) A61K 38/00 (2006.01) A61K 51/00 (2006.01)

Patent

CA 2299389

Breast and/or prostate cancer is diagnosed and/or treated with a radiolabeled peptide or peptidomimetic that binds to GRP (Gastrin Releasing Peptide) receptors.

Un peptide ou un peptidomimétique radiomarqué qui se lie à des récepteurs libérant des gastrines permet de diagnostiquer et/ou de traiter un cancer du sein et/ou de la prostate.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Radiolabeled peptides for the diagnosis and treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Radiolabeled peptides for the diagnosis and treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled peptides for the diagnosis and treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1463439

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.